Promacta 12.5 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F47UV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,406
Award facts
- Contract value 100% obligated
- $25,405.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, issued on January 28, 2026, awards Amerisourcebergen Drug Corp $25,405.65 for the supply of Promacta 12.5 mg tablets (30-count units) to support federal medical procurement needs. The order is non-set-aside and structured as a firm fixed-price delivery order with an ultimate completion date of February 19, 2026. Performance will be executed from the awardee's location in Conshohocken, Pennsylvania. This award is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999.99 million and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
The Defense Logistics Agency, operating under the Department of Defense, funded this procurement as part of its mission to supply critical medical commodities to military treatment facilities and related federal healthcare systems. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor providing an extensive portfolio of brand-name and generic medications across multiple therapeutic domains. The company's federal contracting performance demonstrates consistent capability in fulfilling competitive, open-market pharmaceutical supply requirements for DoD and other government agencies, with this particular order addressing hematology medication needs within the broader pharmaceutical supply chain supporting military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F47UV?
SPE2DR26F47UV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F47UV worth?
The government has obligated $25,406 on SPE2DR26F47UV.
Is contract SPE2DR26F47UV an order under another contract?
Yes. SPE2DR26F47UV is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F47UV competed?
The extent of competition for SPE2DR26F47UV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award